NexMed, Inc.
No bio yet
This person is not in any teams
This person is not in any offices
NexMed, Inc.
NexMed, USA is a wholly owned subsidiary of Apricus Biosciences (NASDAQ:APRI). The Company has a proprietary drug delivery technology, NexACT, which has been used to develop an impressive drug product pipeline, ranging from the pre-clinical stage to the NDA stage.